Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Chloroquine + Velcade + Cyclophosphamide in Relapsed/Refractory Myeloma
NCT01438177Phase 2Terminated
- Sponsor
- NYU Langone Health
- Start
- Oct 2011
- Primary completion
- Feb 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of chloroquine in multiple myeloma (MM), sponsored by NYU Langone Health. Started Oct 2011; status: terminated.
02
Drugs
chloroquine
03
Conditions
multiple myeloma (MM)
Beyond the preview
Go deeper on NCT01438177.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01438177.